Clinical validity and clinical utility of a screening test for Paget's disease of bone

佩吉特骨病筛查试验的临床有效性和临床实用性

• 批准号: 394827
• 负责人: Michou Laetitia N
• 金额: $ 7.29万
• 依托单位: CHU de Qubec
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-09-01 至 2019-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=394827&lang=en
• 关键词: Bone Anabolic Treatment; Bone Biomarkers; Budget Impact Model; Clinical Utility; Clinical Validity; Drug Safety; Health Economic Evaluation; Molecular Test; Osteoporosis; Paget'S Disease Of Bone

Paget's disease of bone (PDB) is a common bone disorder, affecting 2 to 3% of people over 55 years of age and rising up to 6% after the age of 80. This disease may lead to severe disabilities, including fractures and bone deformity. People with PDB may ha

佩吉特骨病 (PDB) 是一种常见的骨病，影响 55 岁以上人群的 2% 至 3%，80 岁后上升至 6%。这种疾病可能导致严重残疾，包括骨折和骨畸形。患有 PDB 的人可能有